DiscGenics
Phase 1/2DiscGenics is focused on developing regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.
Founded
2014
Focus
Cell & Gene TherapyTissue Engineering
About
DiscGenics is focused on developing regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.
Funding History
2Total raised: $30M
Series B$20MUndisclosedJun 15, 2019
Series A$10MUndisclosedJun 15, 2017
Company Info
TypePrivate
Founded2014
LocationSalt Lake City, United States
StagePhase 1/2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile